Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST90011783 | 2021 | Carboplatin drug response (IC50) | NA | 90 | 5,190,917 |
ebi-a-GCST90011784 | 2021 | Cisplatin drug response (IC50) | NA | 90 | 5,190,917 |
ebi-a-GCST90011799 | 2021 | Paclitaxel drug response (AUC) | NA | 87 | 9,342,456 |
ebi-a-GCST90011789 | 2021 | Daunorubicin drug response (IC50) | NA | 86 | 6,245,244 |
ebi-a-GCST90093343 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis in patients positive for neutralising antibodies (antibody titre; IFN<U+03B2>-1a intramuscular) | NA | 86 | 7,612,706 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: